You can contribute to EURION Stakeholders Consultation on test methods for endocrine disruptors (deadline 11 Sept.)

Dear Madam/Sir,

European Cluster to Improve Identification of Endocrine Disruptors, EURION, kindly asks for your input to a first, general scanning of stakeholders’ interests, needs and priorities for the development of test methods for endocrine disruptors (EDs).

EURION ( is a cluster of eight European research projects, funded under EU’s Horizon 2020 framework. The projects are focusing on the development of new ED test methods targeting relevant endpoints that are not sufficiently covered by current regulatory tests.

As a stakeholder of the EURION cluster projects, you are invited to provide your opinion on the most important criteria to be considered for the development of these tests. Your contribution will be critical to allow us to know your views and, ultimately, to develop new tests that are applicable and useful for hazard assessment of EDs. Results of the survey will be presented and discussed at a stakeholder workshop taking place 19 October 2020 (in Brussels or via a digital platform), and for which you will be invited.

Please note that we will handle your data in accordance with the privacy legislation, the General Data Protection Regulation (GDPR) of the EU. The results of the survey will be published without linking them to any personal information. By filling in the questionnaire and submitting it online, you confirm that you have read this information and agree that the information given in the questionnaire may be used for EURION Cluster purposes, including presentations and exchange among relevant stakeholders as well as potential related materials, papers and reports.

Please answer the short (5-10 min) questionnaire by 11 September 2020 via this link:

Best regards,

on behalf of the EURION Cluster,

ENDpoiNTs and ERGO Coordination team.

13 Jan 2020

A letter of Prof. Barbara Demeneix in the Financial Times discusses that chemical pollution is affecting the brain development of future generations often implicating endocrine disruption of epigenetic processes.

24 Aug 2019

ENDpoiNTs  presented at the 17th biannual meeting of the International Neurotoxicology Association (INA), Sept. 29 – Oct. 3 2019, Dusseldorf, Germany. The ENDpoiNTs coordinator and various other researchers presented recent research in the ENDpoiNTs session on “Novel Testing Strategies for Endocrine Disruptors linked to Developmental Neurotoxicity”. Testing strategies based on in vitro batteries, sex-dependent effects of EDCs on hippocampus, to novel approaches to identify neurotoxic modes of action, and endocrine disruption in human neurodevelopmental models were discussed.